Myocardial revascularization with laser. Preliminary findings

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Medical Technology

Background:

• Symptomatic coronary artery disease (CAD) refractory to conventional treatments poses a significant clinical challenge.
• Transmyocardial laser revascularization (TMLR) has emerged as a potential therapeutic option for such patients.

Purpose of the Study:

• To evaluate the efficacy of TMLR as a standalone therapy for patients with severe, refractory CAD.
• To assess the impact of TMLR on angina symptoms, myocardial perfusion, and cardiac function.

Main Methods:

• The study involved 31 patients with symptomatic CAD refractory to medical or interventional treatments.
• TMLR was performed in 21 patients with viable myocardium and demonstrable ischemia.
• Evaluations included positron emission tomography (PET), dobutamine echocardiography, 201Tl single-photon emission computed tomography (201Tl-SPECT), and multigated acquisition radionuclide ventriculography (MUGA).
• Clinical outcomes and functional parameters were assessed at 3 and 6 months post-procedure.

Main Results:

• At 3 months, Canadian Cardiovascular Society (CCS) angina class significantly improved (3.7 to 2.43, P < .05).
• Dobutamine echocardiography showed improved resting wall motion and increased stress left ventricular ejection fraction (LVEF).
• Positron emission tomography (PET) revealed significant improvement in subendocardial to subepicardial perfusion ratio (SEn/SEp) (P < .001 vs control).
• At 6 months, angina class further improved (1.7), and resting wall motion score index increased (P < .05 vs control).
• PET demonstrated sustained improvement in resting SEn/SEp (P < .001 vs control).
• Perioperative and late deaths occurred in patients with preoperative congestive heart failure.

Conclusions:

• TMLR as sole therapy demonstrates significant improvement in anginal status for patients with refractory CAD.
• The procedure enhances relative endocardial perfusion and cardiac function.
• TMLR is a viable option for selected patients, particularly those without preoperative congestive heart failure.